Publication | Closed Access

Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents

Medicinal ChemistryEngineeringMedicineDrug DiscoveryDicationic Bis-benzimidazolesPharmacological AgentOrganic ChemistryNew ClassAntimicrobial ChemotherapyPharmacologyPharmaceutical ChemistryBiomolecular EngineeringAnti-vre Agents